ALLMedicine™ Acne Vulgaris Center

Apr 14th, 2021 - Multiple factors have been attributed to acne vulgaris predisposition and individual variations in the severity of skin symptoms, and genetics stood out as one of the major factors. We performed a systematic review on the genes and their variants ...

Apr 12th, 2021 - Acne vulgaris is a common condition. Alpha hydroxy acid (AHA) peels have been previously recommended as an option for patients with intolerance to first-line treatments especially when long-term use. The safety and efficacy of AHA peels for acne h...

Apr 12th, 2021 - Dermatological diseases, including acne vulgaris, have significant psychosocial effects on patients. To compare body satisfaction, self-esteem, and quality of life (QoL) in adolescents and adults with acne. A total of 192 acne patients (132 female...

Apr 9th, 2021 - Acne vulgaris is common dermatologic condition with an estimated prevalence of 80%. Acne has been shown to have a significant impact on patient quality of life and mental health, especially as inflammatory lesions typically occur on cosmetically s...

Apr 7th, 2021 - Acne is very common and can have substantial impact on wellbeing. Guidelines suggest first line management with topical treatments but there is little evidence regarding which are most effective. To identify the most effective and best tolerated t...

Oct 17th, 2019 - Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its novel AMZEEQTM (minocycline) topical foam, 4%. AMZEEQ, fo...

Oct 14th, 2019 - Acne vulgaris is the most prevalent chronic skin disease in the United States, affecting nearly 50 million people per year, mostly adolescents and young adults. Potential sequelae of acne, such as scarring, dyspigmentation, and low self-esteem, ma...

Oct 3rd, 2019 - The FDA recently approved Galderma’s topical retinoid cream, known as Aklief, for the treatment of acne vulgaris. Additionally, the company reported positive safety profiles for Aklief in two phase 3 clinical trials on acne of both the face and tr...

Nov 23rd, 2018 - Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit associated with socialisation and mental health problems, may affect more than 80% of teenagers. Isotretinoin is the only drug that targets all primary causal factors of acne;...

Nov 13th, 2018 - Acne vulgaris is an inflammatory disorder of pilosebaceous unit, which runs a chronic course and it is self-limiting. Acne vulgaris is triggered by Propionibacterium acnes in adolescence, under the influence of normal circulating dehydroepiandrost...

Apr 14th, 2021 - Multiple factors have been attributed to acne vulgaris predisposition and individual variations in the severity of skin symptoms, and genetics stood out as one of the major factors. We performed a systematic review on the genes and their variants ...

Apr 12th, 2021 - Acne vulgaris is a common condition. Alpha hydroxy acid (AHA) peels have been previously recommended as an option for patients with intolerance to first-line treatments especially when long-term use. The safety and efficacy of AHA peels for acne h...

Apr 12th, 2021 - Dermatological diseases, including acne vulgaris, have significant psychosocial effects on patients. To compare body satisfaction, self-esteem, and quality of life (QoL) in adolescents and adults with acne. A total of 192 acne patients (132 female...

Apr 9th, 2021 - Acne vulgaris is common dermatologic condition with an estimated prevalence of 80%. Acne has been shown to have a significant impact on patient quality of life and mental health, especially as inflammatory lesions typically occur on cosmetically s...

Apr 8th, 2021 - Clindamycin phosphate topical solution USP, 1% is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropr...

Oct 7th, 2020 - In the opinion of Lawrence F. Eichenfield, MD, recent advances in the medical treatment of acne make it "an exciting time" for treating patients with the condition. During the virtual annual Masters of Aesthetics Symposium, he highlighted the foll...

Oct 7th, 2020 - In the opinion of Lawrence F. Eichenfield, MD, recent advances in the medical treatment of acne make it "an exciting time" for treating patients with the condition. During the virtual annual Masters of Aesthetics Symposium, he highlighted the foll...

Aug 26th, 2020 - The Food and Drug Administration has approved clascoterone 1% cream for the topical therapy of acne, providing a treatment with a novel mechanism of action for acne. Clascoterone is a topical androgen receptor inhibitor indicated for treatment of ...

Aug 26th, 2020 - The Food and Drug Administration has approved clascoterone 1% cream for the topical therapy of acne, providing a treatment with a novel mechanism of action for acne. Clascoterone is a topical androgen receptor inhibitor indicated for treatment of ...

Jul 23rd, 2020 - Acne vulgaris is a common chronic skin disease involving blockage and/or inflammation of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Responses to therapeutic agents for acne may vary in people of color, including i...